Evidence map›Paper›PMID 21331196›Full record

ArticleJournal of young pharmacists : JYP2010

Anti-allergic Activity of Stem Bark of Myrica esculenta Buch.-Ham. (Myricaceae).

Kg Patel, Nj Rao, Vg Gajera, Pa Bhatt, Kv Patel, Tr Gandhi

Open access · bronzeAbstract read
In one paragraph

Article in Journal of young pharmacists : JYP, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Plants (Basel, Switzerland) · 2019
    Review
  3. Diarylheptanoids as nutraceutical: A review.Biocatalysis and agricultural biotechnology · 2019
    Review
  4. Some medicinal plants with antiasthmatic potential: a current status.Asian Pacific journal of tropical biomedicine · 2011
    Review
  5. Pharmacognostic characterization of Myrica esculenta leaves.Journal of Ayurveda and integrative medicine
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kg PatelDepartment of Pharmaceutical Chemistry, Anand Pharmacy College, Shri Ram Krishna Seva Mandal Campus, Near Town hall, Anand - 388 001, Gujarat, India.
Nj Rao
Vg Gajera
Pa Bhatt
Kv Patel
Tr Gandhi
Directorate of Medicinal and Aromatic Plants Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic diseases, such as allergic asthma, are hypersensitivity reactions initiated by immunological mechanisms. Myrica esculenta (M. esculenta) is known traditionally in Ayurveda to possess anti-asthmatic activity. The present investigation was undertaken to evaluate the effect of crude extract of stem bark of M. esculenta (Family Myricaceae, commonly known as Kaiphal) on experimental allergic reactions. Experimental models studied were allergic pleurisy and vascular permeability induced by acetic acid in mice. Pretreatment with M. esculenta (75 mg/kg and 150 mg/kg, p.o.) significantly inhibited the eosinophil accumulation (P < 0.01) respectively in the pleural cavity. M. esculenta (75 and 150 mg/kg, p.o.) significantly inhibited the rise in plasma exudation (57.12% and 59.77%, P < 0.01) induced by acetic acid in mice. These findings demonstrate that the crude extract from the stem bark of M. esculenta possesses antiallergic activity. This activity may be mediated by reducing the release of mediators such as histamine, inhibition of mast cell degranulation, and inhibition of eosinophil accumulation thereby preventing the release of cytokines and chemokines.

Indexed as

AllergyeosinophilinflammationMyrica esculentavascular permeability

Identifiers

PMID21331196
PMCPMC3035891
OpenAlexW2021180441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.